BAHRAIN has approved a new medication that can be used to help treat Sickle Cell Disease (SCD) patients from the age of five.
Endari, having been given the green light by the US Food and Drug Administration, has also now been approved for marketing in Bahrain by the National Health Regulatory Authority (NHRA) .
&uuid=(email))